JP2021524850A5 - - Google Patents
Info
- Publication number
- JP2021524850A5 JP2021524850A5 JP2020564431A JP2020564431A JP2021524850A5 JP 2021524850 A5 JP2021524850 A5 JP 2021524850A5 JP 2020564431 A JP2020564431 A JP 2020564431A JP 2020564431 A JP2020564431 A JP 2020564431A JP 2021524850 A5 JP2021524850 A5 JP 2021524850A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- compound
- disorders
- pharmaceutical composition
- equation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862672802P | 2018-05-17 | 2018-05-17 | |
| US62/672,802 | 2018-05-17 | ||
| PCT/US2019/032555 WO2019222438A1 (en) | 2018-05-17 | 2019-05-16 | Tricyclic sulfone compound as a ror gamma modulator |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021524850A JP2021524850A (ja) | 2021-09-16 |
| JP2021524850A5 true JP2021524850A5 (https=) | 2022-05-19 |
Family
ID=66691023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564431A Pending JP2021524850A (ja) | 2018-05-17 | 2019-05-16 | ＲＯＲγ調節剤としての三環スルホン化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10633339B2 (https=) |
| EP (1) | EP3793978A1 (https=) |
| JP (1) | JP2021524850A (https=) |
| KR (1) | KR102829200B1 (https=) |
| CN (1) | CN112119060A (https=) |
| WO (1) | WO2019222438A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4093732A1 (en) | 2020-01-24 | 2022-11-30 | Bristol-Myers Squibb Company | Tricyclic sulfones as ror gamma modulators |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102702044A (zh) | 2006-01-20 | 2012-10-03 | 先灵公司 | 作为γ分泌酶抑制剂的碳环和杂环芳基砜化合物 |
| AR083475A1 (es) * | 2010-10-18 | 2013-02-27 | Merz Pharma Gmbh & Co Kgaa | Moduladores de receptores de glutamato metabotropicos |
| AR104555A1 (es) | 2015-05-07 | 2017-07-26 | Bristol Myers Squibb Co | SULFONAS TRICÍCLICAS COMO MODULARES DE RORg |
| KR102506326B1 (ko) | 2016-10-13 | 2023-03-03 | 브리스톨-마이어스 스큅 컴퍼니 | Ror 감마 조정제로서의 헤테로시클릭 술폰 |
-
2019
- 2019-05-16 CN CN201980032870.8A patent/CN112119060A/zh active Pending
- 2019-05-16 EP EP19728239.5A patent/EP3793978A1/en not_active Withdrawn
- 2019-05-16 WO PCT/US2019/032555 patent/WO2019222438A1/en not_active Ceased
- 2019-05-16 JP JP2020564431A patent/JP2021524850A/ja active Pending
- 2019-05-16 KR KR1020207035905A patent/KR102829200B1/ko active Active
- 2019-05-16 US US16/413,673 patent/US10633339B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Janssens et al. | Pathological roles of the homeostatic chemokine CXCL12 | |
| JP2023506147A5 (https=) | ||
| JP2024071370A5 (https=) | ||
| JP2017079785A5 (https=) | ||
| JP2019516739A5 (https=) | ||
| JP2017509689A5 (https=) | ||
| JP2008200039A5 (https=) | ||
| JP2016506386A5 (https=) | ||
| JP2016199576A5 (https=) | ||
| HRP20161010T1 (hr) | C5ar antagonisti | |
| JP2019515924A5 (https=) | ||
| JP2018140982A5 (https=) | ||
| JP2022550640A5 (https=) | ||
| JP2020500862A5 (https=) | ||
| JP2019529514A5 (https=) | ||
| JP2013529647A5 (https=) | ||
| JP2017528506A5 (https=) | ||
| JP2023085290A (ja) | ＰＩ３Ｋ－γ阻害剤としての三級ヒドロキシ基で置換された縮合イミダゾール誘導体 | |
| CN110770233A (zh) | 稠合双环类化合物及其在药物中的应用 | |
| JP2016164177A5 (https=) | ||
| JP2021500403A5 (https=) | ||
| JP2007522142A5 (https=) | ||
| JP2019531279A5 (https=) | ||
| JP2015528812A5 (https=) | ||
| JP2020534346A5 (https=) |